Chronic myeloproliferative neoplasms Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface
Chronic myeloproliferative neoplasms Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface
复制标题
慢性骨髓增生性肿瘤 突变型钙网蛋白与分泌途径中的 MPL 相互作用,在细胞表面激活
DOI:
--
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
N. Komatsu
中科院分区:
文献类型:
--
作者:
Nami Masubuchi;Marito Araki;Yinjie Yang;Erina Hayashi;M. Imai;Y. Edahiro;Yumi Hironaka;Yoshihisa Mizukami;Yoshihiko Kihara;Hiraku Takei;Mai Nudejima;M. Koike;A. Ohsaka;N. Komatsu
Studies have shown that mutant calreticulin (CALR) constitutively activates the thrombopoietin (TPO) receptor MPL and thus plays a causal role in the development of myeloproliferative neoplasms (MPNs). To further elucidate the molecular mechanism by which mutant CALR promotes MPN development, we studied the subcellular localization of mutant CALR and its importance for the oncogenic properties of mutant CALR. Here, mutant CALR accumulated in the Golgi apparatus, and its entrance into the secretion pathway and capacity to interact with N-glycan were required for its oncogenic capacity via the constitutive activation of MPL. Mutant CALR-dependent MPL activation was resistant to blockade of intracellular protein trafficking, suggesting that MPL is activated before reaching the cell surface. However, removal of MPL from the cell surface with trypsin shut down downstream activation, implying that the surface localization of MPL is required for mutant CALRdependent activation. Furthermore, we found that mutant CALR and MPL interact on the cell surface. Based on these findings, we propose a model in which mutant CALR induces MPL activation on the cell surface to promote MPN development.
影响因子:
28.2
作者:
Elf S;Abdelfattah NS;Chen E;Perales-Patón J;Rosen EA;Ko A;Peisker F;Florescu N;Giannini S;Wolach O;Morgan EA;Tothova Z;Losman JA;Schneider RK;Al-Shahrour F;Mullally A
通讯作者:
Mullally A
影响因子:
8
作者:
Pronier, Elodie;Cifani, Paolo;Levine, Ross L.
通讯作者:
Levine, Ross L.